182 related articles for article (PubMed ID: 22903413)
1. The impact of baseline covariates on the efficiency of statistical analyses of crossover designs.
Yan Z
Stat Med; 2013 Mar; 32(6):956-63. PubMed ID: 22903413
[TBL] [Abstract][Full Text] [Related]
2. On the role of Baseline measurements for crossover designs under the self and mixed carryover effects model.
Liang Y; Carriere KC
Biometrics; 2010 Mar; 66(1):140-8. PubMed ID: 19432775
[TBL] [Abstract][Full Text] [Related]
3. Handling of baseline measurements in the analysis of crossover trials.
Chen X; Meng Z; Zhang J
Stat Med; 2012 Jul; 31(17):1791-803. PubMed ID: 22715129
[TBL] [Abstract][Full Text] [Related]
4. Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studies.
Yan Z; Hosmane B; Locke C
J Biopharm Stat; 2013; 23(4):804-17. PubMed ID: 23786490
[TBL] [Abstract][Full Text] [Related]
5. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
6. Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies.
Parienti JJ; Kuss O
Contemp Clin Trials; 2007 May; 28(3):316-23. PubMed ID: 17110172
[TBL] [Abstract][Full Text] [Related]
7. Conditional analysis of mixed Poisson processes with baseline counts: implications for trial design and analysis.
Cook RJ; Wei W
Biostatistics; 2003 Jul; 4(3):479-94. PubMed ID: 12925513
[TBL] [Abstract][Full Text] [Related]
8. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
Takada M; Sozu T; Sato T
Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
[TBL] [Abstract][Full Text] [Related]
9. CrossOver: an algorithm for the construction of efficient cross-over designs.
John JA; Russell KG; Whitaker D
Stat Med; 2004 Sep; 23(17):2645-58. PubMed ID: 15316948
[TBL] [Abstract][Full Text] [Related]
10. A recommended analysis for 2 × 2 crossover trials with baseline measurements.
Mehrotra DV
Pharm Stat; 2014; 13(6):376-87. PubMed ID: 25230245
[TBL] [Abstract][Full Text] [Related]
11. An efficient analysis of covariance model for crossover thorough QT studies with period-specific baseline days.
Lu K
Pharm Stat; 2013; 12(4):192-200. PubMed ID: 23625584
[TBL] [Abstract][Full Text] [Related]
12. The use of baseline covariates in crossover studies.
Kenward MG; Roger JH
Biostatistics; 2010 Jan; 11(1):1-17. PubMed ID: 19915170
[TBL] [Abstract][Full Text] [Related]
13. HGLM versus conditional estimators for the analysis of clustered binary data.
Kang W; Lee MS; Lee Y
Stat Med; 2005 Mar; 24(5):741-52. PubMed ID: 15696505
[TBL] [Abstract][Full Text] [Related]
14. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
15. Bayesian analyses of two-treatment crossover studies.
Grieve AP
Stat Methods Med Res; 1994 Dec; 3(4):407-29. PubMed ID: 7889229
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of balanced treatment allocation for survival analysis.
Kalish LA; Harrington DP
Biometrics; 1988 Sep; 44(3):815-21. PubMed ID: 3203130
[TBL] [Abstract][Full Text] [Related]
17. Optimal crossover designs for logistic regression models in pharmacodynamics.
Waterhouse TH; Eccleston JA; Duffull SB
J Biopharm Stat; 2006; 16(6):881-94. PubMed ID: 17146986
[TBL] [Abstract][Full Text] [Related]
18. Design and analysis issues for crossover designs in phase I clinical studies.
Boon PC; Roes KC
J Biopharm Stat; 1999 Mar; 9(1):109-28. PubMed ID: 10091913
[TBL] [Abstract][Full Text] [Related]
19. Optimal and efficient crossover designs under different assumptions about the carryover effects.
Hedayat AS; Stufken J
J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
[TBL] [Abstract][Full Text] [Related]
20. Improved power in crossover designs through linear combinations of baselines.
Jemielita T; Putt M; Mehrotra D
Stat Med; 2016 Dec; 35(30):5625-5641. PubMed ID: 27530681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
